Skip to main content
Addex Therapeutics Ltd (SWX:ADXN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
0.0450
-0.0050 (-10.00%)
Mar 9, 2026, 5:31 PM CET

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 49.60K CHF in the quarter ending September 30, 2025, a decrease of -14.99%. This brings the company's revenue in the last twelve months to 158.54K, down -71.81% year-over-year. In the year 2024, Addex Therapeutics had annual revenue of 410.04K, down -74.64%.

Revenue (ttm)
158.54K
Revenue Growth
-71.81%
P/S Ratio
33.09
Revenue / Employee
79.27K
Employees
2
Market Cap
5.25M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024410.04K-1.21M-74.64%
Dec 31, 20231.62M172.23K11.92%
Dec 31, 20221.44M-1.71M-54.18%
Dec 31, 20213.15M-725.84K-18.71%
Dec 31, 20203.88M1.05M36.89%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xlife Sciences AG 839.38K
Molecular Partners AG 681.00K
BioVersys AG 1.31M
Santhera Pharmaceuticals Holding AG 49.02M
Newron Pharmaceuticals 55.93M
Basilea Pharmaceutica AG 232.38M
Idorsia 220.58M
Revenue Rankings

Addex Therapeutics News

More News